L&F Co. Ltd (066970)
Korea Stock Exchange · Korea · prices in KRW · close of 22 Oct 2026
Key indicators
| Last close | KRW 91,200.00 |
|---|---|
| 52-week range | 63,000.00 – 225,000.00 |
| Return, 1 month / 3 months | −15.9% / +10.7% |
| Return, 1 year / 3 years | −21.6% / −38.7% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 92.2% |
| Worst drawdown (1 year) | -69.2% |
| Average daily value traded | 58,828.45M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
L&F Co. Ltd is a Korean materials company that produces cathode active materials for lithium-ion batteries. Its main products are high-nickel cathodes used in battery cells for electric vehicles and energy storage, and it also has roots in electronic materials and display components. Customers are battery manufacturers and electronics firms, mainly in Korea and other Asian markets. The company is based in Daegu, Korea, and operates production facilities there and elsewhere in the country.
On this site L&F Co. Ltd appears as a stock on the Korea Stock Exchange (Korea), code 066970, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
L&F Co. Ltd (066970) trades on the Korea Stock Exchange in Korea. It last closed at KRW 91,200.00 on 22 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 693 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.6% and over the last three months it rose 10.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 25 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -27.4% | ||
| From 52-week high | -57.2% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 10.7% | ||
| 6-month return | -53.2% | ||
| 12-month return, skipping the last month | -6.9% | ||
| Stability (higher is calmer) | 9 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 92.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -69.2% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 58,828.45M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −12.9% |
|---|---|
| 1 month | −15.9% |
| 3 months | +10.7% |
| 6 months | −53.2% |
| 1 year | −21.6% |
| 3 years | −38.7% |
| 5 years | −53.1% |
Signals
| 50-day / 200-day average | 112,498.00 / 125,598.00 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8,871.08 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Dec 2022 | KRW 500.0000 |
| 29 Dec 2020 | KRW 47.8757 |
| 27 Dec 2019 | KRW 46.0614 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.